Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01504477
Recruitment Status : Terminated (Low accrual--unable to meet accrual goals)
First Posted : January 5, 2012
Last Update Posted : July 12, 2017
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Georgetown University

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2014
  Actual Study Completion Date : February 2014